drugset / Trial / NCT04347902

Lipid Emulsions and Liver Function - Results After 5 Years.

NCT04347902

Phase 4 Completed 65 enrolled Stanley Dudrick's Memorial Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Intravenous lipid emulsion (ILE) is an essential component of parenteral nutrition (PN), but also one of the key risk factors for development of intestinal failure associated liver disease (IFALD). The aim of the study was to analyse the influence of ILEs on liver function during long term PN.

Timeline

Start
2016-01
Primary completion
2020-03
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ClinOleic Other / unclassified Intravenous
Subject Lipofundin Other / unclassified Intravenous
Subject SMOFlipid Other / unclassified Intravenous